TribLIVE

| USWorld

 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Subway vigilante Bernie Goetz nabbed in drug sting

Email Newsletters

Click here to sign up for one of our email newsletters.
AP
Bernhard Goetz is arraigned in Manhattan criminal court, in New York, on Saturday, Nov. 2, 2013, on drug charges stemming from the alleged sale of $30 of marijuana to an undercover police officer.

Daily Photo Galleries

'American Coyotes' Series

Traveling by Jeep, boat and foot, Tribune-Review investigative reporter Carl Prine and photojournalist Justin Merriman covered nearly 2,000 miles over two months along the border with Mexico to report on coyotes — the human traffickers who bring illegal immigrants into the United States. Most are Americans working for money and/or drugs. This series reports how their operations have a major impact on life for residents and the environment along the border — and beyond.

By The Associated Press
Saturday, Nov. 2, 2013, 8:27 p.m.
 

NEW YORK — Subway vigilante Bernie Goetz, who ignited a national furor over racism and gun control after he shot four panhandling youths on a train in the 1980s, has been charged with misdemeanor sale and possession of marijuana, authorities said Saturday.

Goetz was nabbed in a sting operation in Union Square park on Friday evening for selling $30 worth of pot to an undercover officer, police said. He asked the woman if she wanted to get high, then went back to his apartment, where he has lived for decades, and returned with marijuana, authorities said. He was arrested on charges of criminal sale of marijuana.

Goetz wasn't being targeted specifically; he just happened to cross paths with the undercover officer assigned to crack down on drug dealing in the park, authorities said.

The 65-year-old was arraigned Saturday in Manhattan Criminal Court on three misdemeanor drug charges for sale and possession of marijuana. He was released on his own recognizance and is due back in court next month. His lawyer couldn't be reached for comment.

Goetz became a household name as the skinny, bespectacled white man who, on Dec. 22, 1984, rose from his seat on the No. 2 train in Manhattan and shot four black teens inside a subway car with an illegal handgun. The teens had sharpened screwdrivers and were asking him for $5. Goetz said it was self-defense and the youths intended to rob him.

The shooting brought to the surface long-smoldering urban issues of race, crime and quality of life. It thrust Goetz, a self-employed electronics expert, into the role of spokesman for what some New Yorkers considered a justified form of vigilantism.

It was a vastly different era. Subway cars were spray-painted with graffiti tags and inhabited by muggers, panhandlers, junkies and the homeless. And crime was out of control — there were about 40 felonies per day in the nation's largest mass transit system. Last year, there were about eight per day, and the figure is declining.

Goetz was cleared of attempted murder charges in 1987 and spent 250 days in jail the same year for a weapons conviction in the case.

In 1996, a Bronx jury awarded one of the teens, Darrell Cabey, $43 million in his lawsuit against Goetz. Cabey's attorney, Ron Kuby, said Saturday his client remains paralyzed in a wheelchair and has never received a penny from Goetz, who had declared bankruptcy.

Subscribe today! Click here for our subscription offers.

 

 


Show commenting policy

Most-Read Nation

  1. Clinton focuses on economy’s future in speech
  2. Hope dims for Fla. teens lost at sea
  3. Oklahoma earthquakes shut down wells
  4. Cat found alive aboard sunken boat pulled from Lake Havasu
  5. Family finds $1M gold treasure in Florida
  6. Congress embraces highway bill
  7. Backers of Colo. school board recall claim 90K signatures
  8. GOP says there’s no deal with Clinton on Benghazi testimony
  9. Minn. man accused of slaying protected Zimbabwean lion says he thought the trip was legal
  10. Artists’ community in Calif. reeling after girl’s death; teen boy arrested
  11. Medicare patients’ outcomes improve